Primary Non-HodgkinÃ¢ÂÂs Lymphomas of the Uterus and Uterine Cervix
- *Corresponding Author:
- Oehler MK
Department of Gynaecological Oncology
Royal Adelaide Hospital, North Terrace
Adelaide, SA 5000, Australia
E-mail: [email protected]
Received Date: January 09, 2017 Accepted Date: March 21, 2017 Published Date: March 25, 2017
Citation: Johannesson L, Mason J, Miller J, Selva-Nayagam S, Oehler MK (2017) Primary Non-Hodgkin’s Lymphomas of the Uterus and Uterine Cervix. Oncol Cancer Case Rep 3: 127. doi: 10.4172/2471-8556.1000127
Copyright: © 2017 Johannesson L, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Objective: Primary malignant non-Hodgkin’s lymphomas in the female genital tract are rare, accounting for less than 1% of all extranodal non-Hodgkin’s lymphomas.
Methods/materials: We report on four cases of primary non-Hodgkin’s lymphomas of the uterus and cervix. Three of our patients were confirmed to be diffuse large B-cell lymphomas (LBCL) and one patient to be T-cell rich LBCL on histopathological examination and immunohistochemical study. One of our three patients who presented with diffuse LBCL was diagnosed with intravascular diffuse LBCL. Other potential origins of disease were excluded.
Results: Two patients were successfully treated with chemotherapy, one with the addition of involved field radiotherapy post chemotherapy, while two had surgery followed by chemotherapy. All four patients are in complete remission with follow up period ranging from 6 months to 5 years.
Conclusions: Gynaecological lymphomas can be a diagnostic challenge due to unspecific symptoms. However, when diagnosed and treated they have a good prognosis. Clinicians should therefore include lymphoma in their differential diagnosis when investigating gynaecological symptoms.